OQS
IVVD icon

Occudo Quantitative Strategies’s Invivyd IVVD Stock Holding History

Occudo Quantitative Strategies’s Portfolio IVVD Stock Details IVVD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-16,017
Closed -$116K – 1226
2021
Q4 		$116K Buy
+16,017
New +$416K 0.01% 943

Other funds holding IVVD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Occudo Quantitative Strategies's IVVD Position: Q1 2022 in Review

Occudo Quantitative Strategies sold out of Invivyd (IVVD) in Q1 2022, closing a stake of 16,017 shares — an estimated $116K sold.

Occudo Quantitative Strategies first reported a position in IVVD in Q4 2021 and held it in 1 quarter. The position peaked at $116K in Q4 2021. 75 funds tracked by Wall St. Rank hold IVVD as of Q1 2022.

  • Occudo Quantitative Strategies reported no remaining Invivyd position as of Q1 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 16,017 Invivyd shares in Q1 2022, an estimated $116K.
  • Occudo Quantitative Strategies first reported a position in Invivyd in Q4 2021 and held it in 1 quarter.
  • Occudo Quantitative Strategies's Invivyd position peaked at $116K in Q4 2021.
  • 75 funds tracked by Wall St. Rank held Invivyd as of Q1 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2022, filed 16 May 2022.